Abstract
With the growing number of individuals regularly using e-cigarettes, it has become increasingly important to understand the psychobiological effects of nicotine salts. Nicotine increases the release of dopamine (DA) into the nucleus accumbens (NAc), causing feelings of satisfaction. However, the differences in the DA-increasing effects of different nicotine salts have not been reported. In this study, we used a G protein-coupled receptor-activated DA fluorescent probe (GRABDA1m) and optical fiber photometric recording equipment to monitor the dynamic changes and kinetics of DA release in the NAc of mice exposed to different e-cigarette aerosols, including nicotine, nicotine benzoate, nicotine tartrate, nicotine lactate, nicotine levulinic acid, nicotine malate, and nicotine citrate. The results of this study were as follows: 1) Different types of nicotine salts could increase the release of DA in the NAc. 2) The slopes and half-effective concentrations of the fitted curves were different, suggesting that each nicotine salt had a difference in the efficiency of increasing DA release with concentration changes. 3) The absorption rates of different nicotine salts containing the same original nicotine concentration were significantly different by measuring the blood nicotine content. The effect of nicotine salts on increasing DA was directly proportional to the blood nicotine level. In conclusion, by observing the effects of nicotine salts on DA release in real time in vivo, differences in the pharmacological effects of nicotine salts are revealed to better understand the mechanism underlying the regulatory effects of nicotine salts on the brain.
Introduction
The rapid evolution of e-cigarette technology has been largely defined by the shift from traditional freebase nicotine to "nicotine salts." By complexing nicotine with organic acids, manufacturers have created formulations that reduce the harshness of high-nicotine aerosols, facilitating deeper inhalation and higher systemic delivery. While these salts are marketed based on user "satisfaction," this psychological state is fundamentally driven by the dopaminergic reward system in the brain, specifically within the nucleus accumbens (NAc).
Despite the widespread use of these formulations, the comparative pharmacological impact of different salts—such as benzoate, lactate, and citrate—on real-time dopamine (DA) kinetics remained poorly understood. This study aimed to map these neural responses to provide a biological basis for the varying addictive potential and user experiences associated with different e-liquid formulations.
Methods and Experimental Design
To capture the rapid dynamics of dopamine release, researchers utilized a combination of advanced neuroengineering and controlled aerosol exposure.
Real-time Neural Monitoring
Mice were prepared via stereotaxic injection of a genetically encoded fluorescent biosensor, GRAB$_{DA1m}$, into the NAc. This sensor, a G protein-coupled receptor-activated DA probe, allows for the high-sensitivity detection of extracellular dopamine levels. Fiber photometry was then used to record these signals in awake, behaving animals during exposure.
Exposure Protocol
Animals were subjected to 60 puffs of e-cigarette aerosol containing either freebase nicotine or one of six organic acid salts (benzoate, tartrate, lactate, levulinic acid, malate, and citrate) at concentrations ranging from 10 to 60 mg/mL. Systemic absorption was verified using high-performance liquid chromatography (HPLC) to measure blood nicotine levels 30 minutes post-exposure.
Key Results and Insights
Differential Dopamine Activation
The study confirmed that while all tested nicotine formulations successfully triggered DA release in the NAc, their efficiency and potency varied significantly depending on the organic acid used. At the highest tested concentration (60 mg/mL), nicotine lactate and nicotine citrate emerged as the most potent triggers, inducing signal increases of approximately 53% and 42%, respectively.
Potency and Sensitivity
By fitting the dose-response data to the Boltzmann equation, the researchers identified two critical pharmacological metrics:
- Potency (EC50): Nicotine lactate exhibited the lowest half-effective concentration, making it the most effective formulation at lower doses.
- Sensitivity (Slope Factor): Nicotine malate showed the highest slope factor, indicating that the brain's reward system is highly sensitive to small changes in the concentration of this specific salt.
The Role of Absorption
A primary finding was the strong positive correlation between blood nicotine levels and peak DA signals. Crucially, different salts containing identical nicotine concentrations resulted in vastly different blood levels. This suggests that the choice of organic acid fundamentally alters how efficiently nicotine crosses respiratory membranes and enters the bloodstream, which in turn dictates the magnitude of the "hit" in the brain.
Discussion and Limitations
This research provides a clear pharmacological link between e-liquid chemistry and neural reward. The finding that DA levels peak during exposure and return to baseline within roughly 40 minutes closely mirrors the usage patterns observed in human vapers.
However, several limitations remain. This study focused on acute exposure; chronic use may lead to neural adaptations or changes in receptor sensitivity not captured here. Additionally, while the mouse NAc is a robust model for reward, human pulmonary architecture and individual vaping behaviors (topography) may influence absorption rates differently. Future research should explore the interaction between these salts and common e-cigarette flavorants, which may further modulate nicotine's impact on the brain.
Summary updated